Print

Print


How evidence-based medicine is failing due to biased trials and selective
publication.
-just in case/por si acaso
-the full paper/el texto íntegro
http://onlinelibrary.wiley.com/doi/10.1111/jep.12147/pdf


2014-05-15 9:40 GMT+02:00 Juan Gérvas <[log in to unmask]>:

> J Eval Clin Pract. <http://www.ncbi.nlm.nih.gov/pubmed/24819404#> 2014
> May 12. doi: 10.1111/jep.12147. [Epub ahead of print]
> How evidence-based medicine is failing due to biased trials and selective
> publication.
> Every-Palmer S<http://www.ncbi.nlm.nih.gov/pubmed?term=Every-Palmer%20S%5BAuthor%5D&cauthor=true&cauthor_uid=24819404>
> 1, Howick J<http://www.ncbi.nlm.nih.gov/pubmed?term=Howick%20J%5BAuthor%5D&cauthor=true&cauthor_uid=24819404>
> .
> Author information <http://www.ncbi.nlm.nih.gov/pubmed/24819404#>
> Abstract
>
> Evidence-based medicine (EBM) was announced in the early 1990s as a 'new
> paradigm' for improving patient care. Yet there is currently little
> evidence that EBM has achieved its aim. Since its introduction, health care
> costs have increased while there remains a lack of high-quality evidence
> suggesting EBM has resulted in substantial population-level health gains.
> In this paper we suggest that EBM's potential for improving patients'
> health care has been thwarted by bias in the choice of hypotheses tested,
> manipulation of study design and selective publication. Evidence for these
> flaws is clearest in industry-funded studies. We argue EBM's indiscriminate
> acceptance of industry-generated 'evidence' is akin to letting politicians
> count their own votes. Given that most intervention studies are industry
> funded, this is a serious problem for the overall evidence base. Clinical
> decisions based on such evidence are likely to be misinformed, with
> patients given less effective, harmful or more expensive treatments. More
> investment in independent research is urgently required. Independent
> bodies, informed democratically, need to set research priorities. We also
> propose that evidence rating schemes are formally modified so research with
> conflict of interest bias is explicitly downgraded in value.
>